skeleton
• isoproterenol did not enhance the generation of osteoclasts when homozygous mutant osteoblasts were co-cultured with wildtype bone marrow macrophages, like it did in wildtype
|
• decreased osteoclast surface in homozygous mutant bones
|
• decreased number of tartrate-resistant acid phosphatase (TRAP)-positive multi-nucleated osteoclasts, indicating defective osteoclast differentiation
|
• bone resorption did not increase in gonadectomized homozygous mutant mice
• decrease in urinary elimination of deoxypyridinoline, a marker of osteoclast function
|
• increased bone volume/tissue volume and bone formation rate, showing a severe high bone mass phenotype at 6 months of age
• long-term leptin intracerebroventricular infusion or gonadectomy did not reduce bone mass of homozygous mutant mice
|
• increased bone formation rate and decreased bone resorption
|
hematopoietic system
• decreased osteoclast surface in homozygous mutant bones
|
• decreased number of tartrate-resistant acid phosphatase (TRAP)-positive multi-nucleated osteoclasts, indicating defective osteoclast differentiation
|
• bone resorption did not increase in gonadectomized homozygous mutant mice
• decrease in urinary elimination of deoxypyridinoline, a marker of osteoclast function
|
immune system
• decreased osteoclast surface in homozygous mutant bones
|
• decreased number of tartrate-resistant acid phosphatase (TRAP)-positive multi-nucleated osteoclasts, indicating defective osteoclast differentiation
|
• bone resorption did not increase in gonadectomized homozygous mutant mice
• decrease in urinary elimination of deoxypyridinoline, a marker of osteoclast function
|
cellular
• decreased number of tartrate-resistant acid phosphatase (TRAP)-positive multi-nucleated osteoclasts, indicating defective osteoclast differentiation
|
• isoproterenol did not enhance the generation of osteoclasts when homozygous mutant osteoblasts were co-cultured with wildtype bone marrow macrophages, like it did in wildtype
|